Letter: infliximab vs. adalimumab in treating ambulatory perianal fistulising Crohn's disease

Aliment Pharmacol Ther. 2014 Jul;40(2):218-20. doi: 10.1111/apt.12828.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Anti-Inflammatory Agents / therapeutic use*
  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Crohn Disease / drug therapy*
  • Humans

Substances

  • Anti-Inflammatory Agents
  • Antibodies, Monoclonal, Humanized